Voice of the Emirates – A new medical study has revealed that moderate coffee consumption may help slow the biological aging process in people with severe mental disorders, including schizophrenia and bipolar disorder. According to the study’s findings, consuming three to four cups of coffee daily was associated with a significant increase in telomere length. These protective caps on DNA are responsible for aging, and their shortening is a key indicator of progressing in aging.
The data showed that participants who regularly consumed coffee experienced an increase in telomere length. This increase is equivalent to a reduction in biological age of approximately five years compared to those who did not drink coffee. These findings are particularly noteworthy, especially since patients with mental health disorders often experience accelerated biological aging. This is attributed to factors related to the illness itself, medications, and daily stressors.
The researchers explained that the link between coffee and slowing aging remains observational and not conclusive evidence of a direct effect. However, it supports previous evidence suggesting the benefits of coffee when consumed in moderation. Hypotheses suggest that the antioxidants and bioactive compounds found in coffee may play a role in protecting cells. They also reduce damage and inflammation.
The study emphasized that these findings do not mean excessive coffee consumption is beneficial. Rather, it underscores that moderation is key. High doses may lead to adverse effects such as increased anxiety or sleep disturbances in some patients. The researchers also called for larger clinical trials to confirm the relationship. They also hope to identify the biological mechanisms linking coffee to slowed aging.
These findings open the door to a deeper understanding of the role of daily habits in improving the health of patients with mental disorders, especially since coffee is a common part of many people’s daily routines. Scientists hope these results will contribute to the development of health guidelines that enhance quality of life. They also hope they will extend the biological lifespan of this patient group.
